Literature DB >> 11121881

Immunohistochemical localization of plasminogen activator inhibitor-1 in rat and human brain tissues.

H Hino1, H Akiyama, E Iseki, M Kato, H Kondo, K Ikeda, K Kosaka.   

Abstract

We investigated immunohistochemically the localization of type 1 plasminogen activator inhibitor (PAI-1) in rat and human brain tissues. In rat, neurons and astrocytes were stained positively for PAI-1 after colchicine treatment. In post-mortem human brain, neurons were stained for PAI-1 but the number of positive neurons varied greatly from case to case. PAI-1 positive astrocytes occurred in the white matter lesions of some patients. In Alzheimer's disease, weak PAI-1 labeling was seen in association with senile plaques and ghost tangles. The present results support a notion that PAI-1 and its target proteases such as plasminogen activators and thrombin are involved in a variety of physiological and pathological processes in brain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11121881     DOI: 10.1016/s0304-3940(00)01679-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

1.  Localization and regulation of the tissue plasminogen activator-plasmin system in the hippocampus.

Authors:  Fernando J Salles; Sidney Strickland
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

2.  Increasing tPA activity in astrocytes induced by multipotent mesenchymal stromal cells facilitate neurite outgrowth after stroke in the mouse.

Authors:  Hongqi Xin; Yi Li; Li Hong Shen; Xianshuang Liu; Xinli Wang; Jing Zhang; Siamak Pourabdollah-Nejad D; Chunling Zhang; Li Zhang; Hao Jiang; Zheng Gang Zhang; Michael Chopp
Journal:  PLoS One       Date:  2010-02-03       Impact factor: 3.240

3.  Increased Serum PAI-1 Levels in Subjects with Metabolic Syndrome and Long-Term Adverse Mental Symptoms: A Population-Based Study.

Authors:  Anne Huotari; Soili M Lehto; Leo Niskanen; Karl-Heinz Herzig; Jukka Hintikka; Heli Koivumaa-Honkanen; Tommi Tolmunen; Kirsi Honkalampi; Noora Kaikkonen; Heimo Viinamäki
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-03-14

4.  The Role of TLR4 and Fyn Interaction on Lipopolysaccharide-Stimulated PAI-1 Expression in Astrocytes.

Authors:  Hyun Myung Ko; Sung Hoon Lee; Ki Chan Kim; So Hyun Joo; Wahn Soo Choi; Chan Young Shin
Journal:  Mol Neurobiol       Date:  2014-08-09       Impact factor: 5.590

5.  Extracellular HIV-1 viral protein R affects astrocytic glyceraldehyde 3-phosphate dehydrogenase activity and neuronal survival.

Authors:  Adriano Ferrucci; Michael R Nonnemacher; Brian Wigdahl
Journal:  J Neurovirol       Date:  2013-06-01       Impact factor: 2.643

6.  Novel Combinatorial Therapeutic Targeting of PAI-1 (SERPINE1) Gene Expression in Alzheimer's Disease.

Authors:  Stacie M Kutz; Craig E Higgins; Paul J Higgins
Journal:  Mol Med Ther       Date:  2012-12-13

7.  Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade.

Authors:  J Steven Jacobsen; Thomas A Comery; Robert L Martone; Hassan Elokdah; David L Crandall; Aram Oganesian; Suzan Aschmies; Yolanda Kirksey; Cathleen Gonzales; Jane Xu; Hua Zhou; Kevin Atchison; Erik Wagner; Margaret M Zaleska; Indranil Das; Robert L Arias; Jonathan Bard; David Riddell; Stephen J Gardell; Magid Abou-Gharbia; Albert Robichaud; Ronald Magolda; George P Vlasuk; Thorir Bjornsson; Peter H Reinhart; Menelas N Pangalos
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-16       Impact factor: 11.205

8.  Beta-amyloidolysis and glutathione in Alzheimer's disease.

Authors:  J Lasierra-Cirujeda; P Coronel; Mj Aza; M Gimeno
Journal:  J Blood Med       Date:  2013-04-15

9.  The TGF-beta1/upstream stimulatory factor-regulated PAI-1 gene: potential involvement and a therapeutic target in Alzheimer's disease.

Authors:  Paul J Higgins
Journal:  J Biomed Biotechnol       Date:  2006

10.  Activators and inhibitors of the plasminogen system in Alzheimer's disease.

Authors:  Rachel Barker; Patrick G Kehoe; Seth Love
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.